Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Hepatitis

Free Subscription Articles published in Gastroenterol Hepatol Retrieve available abstracts of 21 articles: HTML format

Single Articles

December 2025
1. MORENO CO, Romero-Salazar FL, Gomez RM, Jimenez MM, et al
   Effectiveness of Sofosbuvir/Velpatasvir in a Patient with Ultra-Short Bowel Syndrome and Hepatitis C Virus Infection: A Case Report.
   Gastroenterol Hepatol. 2025 Dec 30:502649. doi: 10.1016/j.gastrohep.2025.502649.
   PubMed    
   
   
   October 2025
2. PASCUAL-DAPENA A, Pocurull A, Forns X
   Severe Acute Hepatitis E with Unilateral Amyotrophic Neuralgia: A Diagnostic Challenge.
   Gastroenterol Hepatol. 2025 Oct 7:502585. doi: 10.1016/j.gastrohep.2025.502585.
   PubMed    
   
   
   June 2025
3. FERNANDEZ AS, Valbuena MB, Arroba CM, Dominguez EG, et al
   Prognostic value of early Lille score in patients with severe alcohol-associated hepatitis.
   Gastroenterol Hepatol. 2025 Jun 20:502517. doi: 10.1016/j.gastrohep.2025.502517.
   PubMed     Abstract available
   
   
   
4. CRESPO J, Albillos A, Buti M
   The Spanish National Strategic Plan for Hepatitis C: A legacy of success.
   Gastroenterol Hepatol. 2025 Jun 13:502457. doi: 10.1016/j.gastrohep.2025.502457.
   PubMed    
   
   
   February 2025
5. ROMERO-VICO J, Vargas-Accarino E, Palom A, Fabrellas N, et al
   Utility of mobile applications in the management of hepatitis B: A systematic review.
   Gastroenterol Hepatol. 2025 Feb 19:502395. doi: 10.1016/j.gastrohep.2025.502395.
   PubMed     Abstract available
   
   
   January 2025
6. LUIS CASTRO URDA J, Alvarez M, Cantero H, Ayala V, et al
   The efficiency of artificial intelligence for management and clinical decision-making in the identification of patients with undiagnosed HCV infection (Intelligen-C strategy).
   Gastroenterol Hepatol. 2025 Jan 18:502362. doi: 10.1016/j.gastrohep.2025.502362.
   PubMed     Abstract available
   
   
   
7. FORNS X, Rodriguez M, Dominguez-Hernandez R, Cantero H, et al
   Cost analysis of hidden hepatitis D virus infection in Spain.
   Gastroenterol Hepatol. 2025 Jan 8:502337. doi: 10.1016/j.gastrohep.2025.502337.
   PubMed     Abstract available
   
   
   December 2024
8. JIMENEZ-CASTILLO RA, Gonzalez-Martinez CE, Tovar-Bojorquez EM, Cortez-Hernandez CA, et al
   Prognostic value of relative adrenal insufficiency in patients with severe alcohol-associated hepatitis-a prospective clinical study.
   Gastroenterol Hepatol. 2024 Dec 12:502322. doi: 10.1016/j.gastrohep.2024.502322.
   PubMed     Abstract available
   
   
   November 2024
9. LOPEZ DE LA CRUZ J, Gonzalvo MCA, Ortiz de Solorzano Reig M, Aguilar A, et al
   Acute cholestatic hepatitis secondary to idiopathic adult ductopenia.
   Gastroenterol Hepatol. 2024 Nov 14:502289. doi: 10.1016/j.gastrohep.2024.502289.
   PubMed    
   
   
   
10. MIRALPEIX A, Ibanez P, Navarro V, Colomera P, et al
    Externalised nurse-led model for hepatitis C virus microelimination and impact of drug use profile.
    Gastroenterol Hepatol. 2024 Nov 13:502288. doi: 10.1016/j.gastrohep.2024.502288.
    PubMed     Abstract available
    
    
    October 2024
11. LUO JX, Chen G, Hu XY, Yu C, et al
    Tenofovir alafenamide versus entecavir in treating patients with chronic hepatitis B: A meta-analysis.
    Gastroenterol Hepatol. 2024 Oct 17:502276. doi: 10.1016/j.gastrohep.2024.502276.
    PubMed     Abstract available
    
    
    September 2024
12. BUTI M, Calleja JL, Rodriguez MA, Dominguez-Hernandez R, et al
    Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D.
    Gastroenterol Hepatol. 2024 Sep 7:502241. doi: 10.1016/j.gastrohep.2024.502241.
    PubMed     Abstract available
    
    
    June 2024
13. BOLIS F, Cazzaniga G, Pagni F, Invernizzi P, et al
    The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis variants.
    Gastroenterol Hepatol. 2024 Jun 29:502225. doi: 10.1016/j.gastrohep.2024.502225.
    PubMed     Abstract available
    
    
    
14. PARADA VAZQUEZ P, Perez-Cachafeiro S, Castineira Dominguez B, Gonzalez-Perez JM, et al
    Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnes (Spain).
    Gastroenterol Hepatol. 2024 Jun 29:502226. doi: 10.1016/j.gastrohep.2024.502226.
    PubMed     Abstract available
    
    
    
15. RODRIGUEZ-TAJES S, Palom A, Giraldez Gallego A, Moreno A, et al
    Characterizing Hepatitis Delta in Spain and the gaps in its management.
    Gastroenterol Hepatol. 2024 Jun 20:502222. doi: 10.1016/j.gastrohep.2024.502222.
    PubMed     Abstract available
    
    
    May 2024
16. ESTEBAN R, Hernandez RD, Cantero H, Casado MA, et al
    Evaluacion del valor clinico y economico de sofosbuvir/velpatasvir (SOF/VEL) en pacientes con hepatitis C cronica en Espana durante los ultimos 5 anos.
    Gastroenterol Hepatol. 2024 May 7:502199. doi: 10.1016/j.gastrohep.2024.502199.
    PubMed     Abstract available
    
    
    February 2024
17. JORQUERA F, Ledesma F, Ahumada A, Manzano ML, et al
    Clinical profile of Spanish hepatitis C virus-infected treatment-naive patients with compensated cirrhosis in the CREST study.
    Gastroenterol Hepatol. 2024 Feb 12:S0210-5705(24)00037.
    PubMed     Abstract available
    
    
    
18. LIU Y, Chen S, Yu S, Wang J, et al
    LPS-TLR4 pathway exaggerates alcoholic hepatitis via provoking NETs formation.
    Gastroenterol Hepatol. 2024;47:158-169.
    PubMed     Abstract available
    
    
    December 2023
19. CONTHE A, Ahumada A, Gallego Duran R, Marti-Aguado D, et al
    Current dilemmas in hepatitis virus C management. What should we do after achieving sustained virologic response?
    Gastroenterol Hepatol. 2023;46:826-829.
    PubMed    
    
    
    
20. RIVEIRO-BARCIELA M, Roade L, Martinez-Camprecios J, Vidal-Gonzalez J, et al
    mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
    Gastroenterol Hepatol. 2023;46:764-773.
    PubMed     Abstract available
    
    
    
21. ARZALLUS T, Izagirre A, Castiella A, Torrente S, et al
    Drug induced autoimmune hepatitis after turmeric intake.
    Gastroenterol Hepatol. 2023;46:805-806.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.